STOKE THERAPEUTICS INC's ticker is STOK and the CUSIP is 86150R107. A total of 108 filers reported holding STOKE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,353,732 | -40.8% | 851,201 | +59.7% | 0.12% | -31.6% |
| Q2 2023 | $5,664,514 | +12.7% | 532,880 | -11.7% | 0.17% | +13.7% |
| Q1 2023 | $5,027,355 | -1.0% | 603,524 | +9.7% | 0.15% | -1.3% |
| Q4 2022 | $5,078,521 | +52.7% | 550,219 | +112.4% | 0.16% | +42.2% |
| Q3 2022 | $3,326,000 | +26.8% | 259,014 | +30.4% | 0.11% | +21.1% |
| Q2 2022 | $2,624,000 | – | 198,621 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ATP Life Science Ventures, L.P. | 16,786,713 | $391,802,000 | 74.38% |
| RTW INVESTMENTS, LP | 3,544,248 | $84,459,000 | 2.38% |
| Cormorant Asset Management, LP | 1,701,292 | $40,542,000 | 1.55% |
| Redmile Group, LLC | 2,502,306 | $59,630,000 | 1.10% |
| RA Capital Management | 1,119,963 | $26,689,000 | 0.52% |
| HighVista Strategies LLC | 17,734 | $423,000 | 0.35% |
| GILDER GAGNON HOWE & CO LLC | 1,569,564 | $37,403,000 | 0.29% |
| Birchview Capital, LP | 20,000 | $477,000 | 0.29% |
| Perceptive Advisors | 671,978 | $16,013,000 | 0.26% |
| Artal Group S.A. | 285,000 | $6,792,000 | 0.19% |